Healthcare -
Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - CASH FROM OPERATIONS
Cash from Operations VIRX - Viracta Therapeutics, Inc.
-39.9 M
LAST VALUE
-45.47%
2 YEAR CAGR
-10.33%
5 YEAR CAGR
-0.64%
10 YEAR CAGR